Efficacy and Safety of Tranexamic Acid Versus ϵ-Aminocaproic Acid in Cardiovascular Surgery

Annals of Pharmacotherapy

Volumn 48, Issue 12, 2014, Pages 1563-1569

  Falana, Olabisi ^a   Patel, Gourang ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

antifibrinolytic; bleeding; cardiopulmonary bypass; cardiovascular surgery; cost; hematology

Indexed keywords

AMINOCAPROIC ACID; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CHEST TUBE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SEIZURE; THROMBOEMBOLISM; TREATMENT OUTCOME; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMPARATIVE STUDY; MIDDLE AGED;

AGED; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84921467554     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014549558     Document Type: Article

References (26)

1. Herbertson M.Recombinant activated factor VII in cardiac surgery.Blood Coagul Fibrinolysis. 2004;15:S31-S32
2. Ipema HJ,Tanzi MG.Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.Ann Pharmacother. 2012;46:97-107
3. Dietrich W,Spannagl M,Boehm J, et al.Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.Anesth Analg. 2008;107:1469-1478
4. Billings FT,Balaguer JM,Yu C, et al.Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass.Clin Pharmacol Ther. 2012;91:1065-1073
5. Ferraris VA,Brown JR,Despotis GJ, et al.2011 Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.Ann Thorac Surg. 2011;91:944-982
6. Ferraris SP,Ferraris VA,Saha SP, et al.Perioperative blood transfusion and blood conservation in cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.Ann Thorac Surg. 2007;83:S27-S86
7. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.Anesthesiology. 2006;105:198-208
8. Sullivan MT,Cotten R,Read EJ,Wallace EL.Blood collection and transfusion in the United States in 2001.Transfusion. 2007;47:385-394
9. Shander A,Hofmann A,Ozawa S,Theusinger O,Gombotz H,Spahn D.Activity-based costs of blood transfusions in surgical patients at four hospitals.Transfusion. 2010;50:753-765
10. Spiess BD.Blood transfusion: the silent epidemic.Ann Thorac Surg. 2001;72:S1832-S1837
11. Henry DA,Carless PA,Moxey AJ, et al.Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.Cochrane Database Syst Rev. 2011; (3): CD001886
12. Slaughter TF,Greenberg CS.Antifibrinolytic drugs and perioperative hemostasis.Am J Hematol. 1997;56:32-36
13. Ottawa, ON, Canada: Pfizer; 2010:
14. Shirley, NY: American Regent; 2005:
15. West Haven, CT: Bayer Pharmaceuticals; 2003:
16. Camarasa MA,Ollé G,Serra-Prat M, et al.Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial.Br J Anaesth. 2006;96:576-582
17. Fergusson DA,Hébert PC,Mazer CD, et al.A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.N Engl J Med. 2008;358:2319-2331
18. Koster A,Borgermann J,Zittermann A,Lueth JU,Gillis-Junuszeuwski T,Schirmer U.Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome.Br J Anaesth. 2013;110:34-40
19. Manji RA,Grocott HP,Leake J, et al.Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors.Can J Anaesth. 2012;59:6-13
20. Kalavrovziotis D,Voisine P,Mohammadi S,Dionne S,Dagenais F.Hgh-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass.Ann Thorac Surg. 2012;93:148-154
21. Raghunathan K,Connelly NR,Kanter GJ.ϵ-Aminocaproic acid and clinical value in cardiac anesthesia.J Cardiothorac Vasc Anesth. 2011;25:16-19
22. American Society of Health-System Pharmacists Current Drug Shortages. Aminocaproic acid injection. http://www.ashp.org/menu/DrugShortages/CurrentShortages/Bulletin.aspx?id=789. Accessed Sep-tember 3, 2011.
23. McCormack PL.Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.Drugs. 2012;72:585-617
24. Ker K,Edwards P,Perel P,Shakur H,Roberts I.Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.BMJ. 2012;344:e3054
25. Eubanks JD.Antifibrinolytics in major orthopaedic surgery.J Am Acad Orthop Surg. 2010;18:132-138
26. Gill JB,Chin Y,Levin A,Feng D.The use of antifibrinolytic agents in spine surgery: a meta-analysis.J Bone Joint Surg Am. 2008;90:2399-2407